We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.52%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$6.95B
AUM Growth
-$2.73B
(-28%)
Cap. Flow
-$3.36B
Cap. Flow
% of AUM
-48.41%
Top 10 Holdings %
Top 10 Hldgs %
42.49%
Holding
191
New
39
Increased
28
Reduced
38
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$572M |
| 2 |
Wells Fargo
WFC
|
+$202M |
| 3 |
Comcast
CMCSA
|
+$195M |
| 4 |
KeyCorp
KEY
|
+$162M |
| 5 |
Halliburton
HAL
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$416M |
| 2 |
Amazon
AMZN
|
+$342M |
| 3 |
Broadcom
AVGO
|
+$304M |
| 4 |
Bank of America
BAC
|
+$283M |
| 5 |
Bausch Health
BHC
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.13% |
| 2 | Materials | 13.12% |
| 3 | Healthcare | 11.58% |
| 4 | Energy | 10.24% |
| 5 | Industrials | 8.47% |
Similar funds
CIP
IMRF
SF
CMTU
PGFC
EGM
PA
MT
PointState Capital's Q4 2016 Portfolio in Review
As of Q4 2016, PointState Capital held 191 positions worth $6.95B, down 28% from $9.69B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
PointState Capital withdrew a net $3.36B in Q4 2016, closing 75 positions and reducing 38 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $416M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 7.8% a quarter earlier, followed by Materials and Healthcare.
Against the trend, PointState Capital opened a new position in LyondellBasell Industries worth $585M.
- PointState Capital's largest Q4 2016 buy was LyondellBasell Industries: 6,816,267 shares worth $585M.
- PointState Capital added most to Wells Fargo in Q4 2016, an estimated $202M increase.
- PointState Capital's biggest Q4 2016 reduction was Amazon, cutting an estimated $342M.
- PointState Capital fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $416M.
- PointState Capital's ten largest holdings make up 42% of its $6.95B portfolio in Q4 2016.
- PointState Capital opened 39 new positions and closed 75 in Q4 2016.
- PointState Capital's portfolio value fell 28% quarter-over-quarter to $6.95B.
Based on PointState Capital's 13F filing for Q4 2016, filed 14 Feb 2017.